tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,542 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$19.85
$14.82B
151.26%
10 Buy
0 Hold
1 Sell
Strong Buy
BioMarin Pharmaceutical
$56.24
$10.79B
20.87
-34.64%
13 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$41.36
$11.39B
18.94
91.81%
10 Buy
6 Hold
0 Sell
Moderate Buy
Incyte
$71.22
$13.79B
220.36
12.00%
7 Buy
11 Hold
1 Sell
Moderate Buy
United Therapeutics
$288.56
$13.02B
11.52
-5.71%
7 Buy
3 Hold
0 Sell
Moderate Buy
Genmab
$22.03
$14.04B
12.83
-14.61%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
19.95
12.01
151.26%
BMRN
BioMarin Pharmaceutical
55.00
-29.15
-34.64%
EXEL
Exelixis
41.36
19.80
91.84%
INCY
Incyte
68.81
7.37
12.00%
UTHR
United Therapeutics
288.56
-17.48
-5.71%
GMAB
Genmab
22.03
-3.77
-14.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis